TCRCure Revenue and Competitors
Estimated Revenue & Valuation
- TCRCure's estimated annual revenue is currently $4.3M per year.
- TCRCure's estimated revenue per employee is $155,000
Employee Data
- TCRCure has 28 Employees.
- TCRCure grew their employee count by -3% last year.
TCRCure's People
| Name | Title | Email/Phone |
|---|
TCRCure Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is TCRCure?
TCRCure Biopharma Ltd. aims to develop next generation cancer immunotherapies that control tumor progression, convert life-threatening cancers to manageable diseases, and eventually lead to cures. We are a leading international company focused on streamlined biotechnology development including high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TCRCure News
2022-04-06 - China VC Investment List Q1 2022 Healthcare
TCRCure was established in 2016, focusing on the tumor immune cell therapy technology.. Hugo Biotech. Pathogenic microorganism sequencing...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 28 | 33% | $7M |
#2 | $4.1M | 28 | -3% | N/A |
#3 | $2.8M | 28 | N/A | N/A |
#4 | $5.3M | 28 | N/A | N/A |
#5 | $2.8M | 28 | N/A | N/A |